In Vitro Diagnostics (IVD) Quality Control Market Poised for Strong Growth Amid Rising Demand for Accurate Diagnostics: Verified Market Research®
The In Vitro Diagnostics (IVD) Quality Control Market is driven by the increasing prevalence of chronic and infectious diseases, growing adoption of point-of-care testing, and technological advancements in diagnostics. However, high system costs, shortage of skilled professionals, and complex regulatory frameworks pose significant challenges, affecting adoption rates and limiting market penetration in price-sensitive regions.
LEWES, Del., Sept. 24, 2025 /PRNewswire/ -- The Global In Vitro Diagnostics (IVD) Quality Control Market Size is projected to grow at a CAGR of 6.66% from 2024 to 2031, according to a new report published by Verified Market Research®. The report reveals that the market was valued at USD 686.78 Million in 2024 and is expected to reach USD 1150.36 Million by the end of the forecast period.
The IVD Quality Control Market is witnessing significant growth as healthcare providers prioritize accurate and reliable diagnostic testing.
- Advancements in molecular diagnostics, automation, and point-of-care (POC) testing are accelerating market adoption.
- Regional growth is supported by expanding healthcare infrastructure and adherence to regulatory compliance standards.
For a detailed analysis of industry trends and growth drivers, explore the full In Vitro Diagnostics (IVD) Quality Control Market.
Browse in-depth TOC
202 - Pages
126 - Tables
37 - Figures
Global In Vitro Diagnostics (IVD) Quality Control Market Overview
Market Driver
1. Rising Prevalence of Chronic and Infectious Diseases
- Global burden of chronic illnesses like diabetes, cardiovascular disorders, and cancer continues to rise.
- Frequent outbreaks of infectious diseases such as COVID-19 increase diagnostic demand.
- Laboratories and hospitals invest in advanced IVD quality control systems to minimize errors.
- Ensuring compliance and improving patient safety remains a top priority.
2. Growing Adoption of Point-of-Care Testing and Molecular Diagnostics
- Rapid adoption of decentralized testing solutions is boosting demand for quality control.
- Point-of-care devices in hospitals, clinics, and home care require reliable validation.
- Molecular diagnostics, essential for early disease detection, need stringent quality control.
- Personalized medicine drives further demand for consistent and precise diagnostic performance.
3. Technological Advancements and Regulatory Compliance Requirements
- Automation, digital platforms, and next-generation assays are increasingly integrated into diagnostics.
- Regulatory agencies such as FDA, EMA, and WHO enforce strict compliance standards.
- Quality control systems ensure consistent performance and minimize variability.
- Investments in technology and regulatory readiness support steady market growth.
Market Restraints
1. High Cost of Quality Control Systems and Consumables
- Advanced equipment and reference materials are expensive, limiting adoption in smaller labs.
- Budget constraints are a major barrier, especially in emerging economies.
- Price-sensitive markets delay investment in modern quality control technologies.
- Cost concerns directly impact market penetration and growth potential.
2. Shortage of Skilled Professionals and Training Gaps
- Skilled personnel are essential to maintain quality control accuracy.
- Developing regions face a lack of trained professionals in advanced testing protocols.
- Poor handling or mismanagement of instruments compromises results.
- Training gaps slow the adoption of sophisticated quality control solutions.
3. Stringent and Complex Regulatory Frameworks
- Compliance requirements vary across regions, creating operational complexity.
- Regulatory approvals such as FDA or CE marking can delay product launches.
- High compliance costs reduce scalability for smaller market players.
- Navigating multiple regulations restricts market expansion and competitiveness.
Download a free sample to access exclusive insights, data charts, and forecasts from the In Vitro Diagnostics (IVD) Quality Control Market Sample Report.
Geographical Dominance: North America dominates the In Vitro Diagnostics (IVD) Quality Control Market due to its advanced healthcare infrastructure, high adoption of molecular diagnostics, and well-established regulatory frameworks. The U.S. serves as a major hub with significant investments in hospital laboratories and diagnostic centers. Europe follows closely, driven by strict regulatory standards and the increasing focus on personalized medicine. The Asia-Pacific region is emerging rapidly, supported by growing healthcare spending, expanding laboratory networks, and rising awareness of quality control in diagnostics.
Key Players
The "Global In Vitro Diagnostics (IVD) Quality Control Market" study report will provide a valuable insight with an emphasis on the global market. The major players in the market are Abbott Laboratories, Bio-Rad Laboratories, Danaher Corporation, Helena Laboratories, LGC Limited, Randox Laboratories, Roche Diagnostics, SeraCare Life Sciences, Siemens Healthineers, Sysmex Corporation.
In Vitro Diagnostics (IVD) Quality Control Market Segment Analysis
Based on the research, Verified Market Research has segmented the global market into Product Type, Application, End-User, and Geography.
- In Vitro Diagnostics (IVD) Quality Control Market, by Product Type
- Quality Control Products
- Data Management Solutions
- In Vitro Diagnostics (IVD) Quality Control Market, by Application
- Clinical Chemistry
- Immunoassays
- Molecular Diagnostics
- Microbiology
- In Vitro Diagnostics (IVD) Quality Control Market, by End-User
- Hospitals and Diagnostic Laboratories
- Academic and Research Institutions
- Point-of-Care Testing
- In Vitro Diagnostics (IVD) Quality Control Market, by Geography
- North America
- U.S
- Canada
- Mexico
- Europe
- Germany
- France
- U.K
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- ROW
- Middle East & Africa
- Latin America
- North America
Strategic Insight:
The market drivers and restraints highlight a landscape of both strong growth potential and operational challenges. High demand from chronic disease management and technological adoption creates ample opportunities for manufacturers and investors. However, cost barriers, workforce shortages, and complex regulations require careful planning for market entry. Companies focusing on innovative, cost-effective solutions and offering training and support services are likely to gain a competitive advantage. Geographical trends suggest North America and Europe provide stable, high-value markets, while Asia-Pacific offers long-term growth prospects, making a balanced global strategy essential for maximizing returns.
To gain complete access with corporate or enterprise licensing, visit the In Vitro Diagnostics (IVD) Quality Control Market.
Key Highlights of the Report:
- Market Size & Forecast: In-depth analysis of current value and future projections
- Segment Analysis: Breaks down the market by Product Type, Application, and End-User for focused strategy development.
- Regional Insights: Comprehensive coverage of North America, Europe, Asia-Pacific, and more
- Competitive Landscape: Profiles key players, their strategic initiatives, and innovation-driven growth approaches.
- Growth Drivers & Challenges: Analyzes the forces accelerating growth and the restraints hindering large-scale adoption.
- Challenges and Risk Assessment: Evaluates ethical debates, off-target effects, and regulatory complexities.
Why This Report Matters:
This report delivers actionable insights on market dynamics, competitive landscape, regional trends, and investment opportunities. It equips healthcare providers, diagnostic manufacturers, and B2B clients with the knowledge required to make strategic decisions and drive revenue in the IVD quality control sector.
Who You Should Read This Report:
- Market Research Professionals
- B2B Clients, Healthcare Providers, and Laboratories
- Diagnostic Manufacturers and Industrialists
- Investors, Consultants, and Policy Makers
Browse Related Reports:
Global In Vitro Lung Model Market Size By Type (2D Models, 3D Models), Application (Drug Screening, Toxicology), By Geography, And Forecast
Global In Vitro Diagnostic (IVD) Products Market Size By Product Type (Reagents & Kits, Instruments, Software & Services), By Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Haematology), By Application (Infectious Diseases, Diabetes, Oncology, Cardiology), By Test Location (Laboratory Tests, Point-of-Care Tests), By End-User (Hospitals Laboratories, Diagnostic Laboratories, Academic & Research Institutes, Home Care), By Geographic Scope And Forecast, By Geography, And Forecast
UAE In-Vitro Diagnostics Market Size By Product (Instrument, Reagent, Service), By Technology (Immunoassay, Hematology, Clinical Chemistry, Molecular Diagnostics, Microbiology), By Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology), By End-User (Hospitals & Clinics, Diagnostic Centers & Laboratories), By Geographic Scope And Forecast
Global Cardiotoxicity Screening Market Size By Product Type (In-vitro Testing Kits, In-vivo Testing Models, Analytical Instruments, Software for Data Analysis), By Technology (Electrophysiology, Biomarker Assays, High-Throughput Screening), By Application (Drug Development, Toxicology Studies, Preclinical Screening, Clinical Trials), By Geographic Scope And Forecast
Top 7 In-Vitro Toxicology Testing Companies liberating environment from toxic substances
Visualize In Vitro Diagnostics (IVD) Quality Control Market using Verified Market Intelligence -:
Verified Market Intelligence is our BI Enabled Platform for narrative storytelling in this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.
VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.
About Us
Verified Market Research® stands at the forefront as a global leader in Research and Consulting, offering unparalleled analytical research solutions that empower organizations with the insights needed for critical business decisions. Celebrating 10+ years of service, VMR has been instrumental in providing founders and companies with precise, up-to-date research data.
With a team of 500+ Analysts and subject matter experts, VMR leverages internationally recognized research methodologies for data collection and analyses, covering over 15,000 high impact and niche markets. This robust team ensures data integrity and offers insights that are both informative and actionable, tailored to the strategic needs of businesses across various industries.
VMR's domain expertise is recognized across 14 key industries, including Semiconductor & Electronics, Healthcare & Pharmaceuticals, Energy, Technology, Automobiles, Defense, Mining, Manufacturing, Retail, and Agriculture & Food. In-depth market analysis cover over 52 countries, with advanced data collection methods and sophisticated research techniques being utilized. This approach allows for actionable insights to be furnished by seasoned analysts, equipping clients with the essential knowledge necessary for critical revenue decisions across these varied and vital industries.
Verified Market Research® is also a member of ESOMAR, an organization renowned for setting the benchmark in ethical and professional standards in market research. This affiliation highlights VMR's dedication to conducting research with integrity and reliability, ensuring that the insights offered are not only valuable but also ethically sourced and respected worldwide.
Follow Us On: LinkedIn | Twitter | Threads | Instagram | Facebook
Contact Us
Mr. Edwyne Fernandes
Verified Market Research®
US: +1 (650)-781-4080
US Toll Free: +1 (800)-782-1768
Email: sales@verifiedmarketresearch.com
Web: https://www.verifiedmarketresearch.com/
Logo: https://mma.prnewswire.com/media/2015407/VMR_Logo.jpg
View original content: